OOIR: Observatory of International Research

Papers

(The TQCC of Neuropathology and Applied Neurobiology is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)

Article	Citations
Intelligence quotient–genotype association in dystrophinopathies: A systematic review and meta‐analysis	125
Neuronal infection is a major pathogenetic mechanism and cause of fatalities in human acute Nipah virus encephalitis	61
An autopsy case of late‐onset spinocerebellar atrophy type 14	50
Oral Abstracts	31
Editorial	30
Potent T cell‐mediated anti‐inflammatory role of the selective CB2 agonist lenabasum in multiple sclerosis	28
Neuropathological Characterisation of McLeod Syndrome With a Proposed New Grading System	25
Paediatric astroblastoma‐like neuroepithelial tumour of the spinal cord with a MAMLD1‐BEND2 rearrangement	24
Novel naturally occurring autoantibodies attenuate α‐synuclein pathology in a mouse model of Parkinson's disease	24
	23
	23
The S1PR2‐CCL2‐BDNF‐TrkB pathway mediates neuroinflammation and motor incoordination in hyperammonaemia	23
Synaptic gene expression changes in frontotemporal dementia due to the MAPT 10 + 16 mutation	22
Anaplastic ganglioglioma—A diagnosis comprising several distinct tumour types	21
Analysing cerebrospinal fluid with explainable deep learning: From diagnostics to insights	21
A novel SREBF1::NACC1 gene fusion in an unclassifiable intracranial tumour	21
Author Index	20
Neuronal and astrocytic tetraploidy is increased in drug‐resistant epilepsy	19
Erratum	19
Myostatin in idiopathic inflammatory myopathies: Serum assessment and disease activity	18
Myopathology and Immune Profile of Granulomatous Myositis in Sarcoid Myopathy	16
124th Meeting of the British Neuropathological Society The View, Royal College of Surgeons of England, Lincoln's Inn Fields, London	16
Response letter: Complexities in pericyte markers	16
Cover Image, Volume 50, Issue 3	16
Genetic inhibition of PDK1 robustly reduces plaque deposition and ameliorates gliosis in the 5×FAD mouse model of Alzheimer's disease	16

A standardised protocol for blood and cerebrospinal fluid collection and processing for biomarker research in ataxia	16
Rapid bacterial identification from formalin‐fixed paraffin‐embedded neuropathology specimens using 16S rDNA nanopore sequencing	16
	15
Perineuronal nets are phagocytosed by MMP‐9 expressing microglia and astrocytes in the SOD1^G93A ALS mouse model	15
Image‐based deep learning reveals the responses of human motor neurons to stress and VCP‐related ALS	15
Non‐coding regulatory elements: Potential roles in disease and the case of epilepsy	15
Issue Information	15
	15
Concurrent tau pathologies in frontotemporal lobar degeneration with TDP‐43 pathology	15
Evidence of neural crest cell origin of a DICER1 mutant CNS sarcoma in a child with DICER1 syndrome and NRAS‐mutant neurocutaneous melanosis	15
Phenotypic and epigenetic heterogeneity in FGFR2‐fused glial and glioneuronal tumours	14
Low‐grade epilepsy‐associated neuroepithelial tumours with a prominent oligodendroglioma‐like component: The diagnostic challenges	14
Fibrodysplasia ossificans progressiva: Histopathological implications of aberrant bone morphogenic protein signalling for CNS dysgenesis	14
Application of Oral Mucosal Epithelial Cells in Noninvasive Pathological Diagnosis of Neuronal Intranuclear Inclusion Disease	14
TDP‐43 pathology and functional deficits in wild‐type and ALS/FTD mutant cyclin F mouse models	14
The autophagy‐enhancing drug carbamazepine improves neuropathology and motor impairment in mouse models of Machado–Joseph disease	14
Adult‐onset Alexander disease with unusual inflammatory features and a novel GFAP mutation in two patients	14
Epigenetic age acceleration is associated with oligodendrocyte proportions in MSA and control brain tissue	14
Microglia induce an interferon‐stimulated gene expression profile in glioblastoma and increase glioblastoma resistance to temozolomide	13
RNA sequencing of peripheral blood in amyotrophic lateral sclerosis reveals distinct molecular subtypes: Considerations for biomarker discovery	13
m⁶A mRNA methylation in human brain is disrupted in Lewy body disorders	13
Robust methylation‐based classification of brain tumours using nanopore sequencing	13
The genomic landscape of dysembryoplastic neuroepithelial tumours and a comprehensive analysis of recurrent cases	12
Hippocampal dentate granule cells in temporal lobe epilepsy: A morphometry and transcriptomic study	12
MiR‐142‐3p regulates synaptopathy‐driven disease progression in multiple sclerosis	12
Neurotherapeutic implications of sense and respond strategies generated by astrocytes and astrocytic tumours to combat pH mechanical stress	12
The blood–CSF–brain route of neurological disease: The indirect pathway into the brain	12
Comprehensive analysis of intratumoural heterogeneity of somatic copy number alterations in diffuse glioma reveals clonality‐dependent prognostic patterns	12
126^th Meeting of the British Neuropathological Society The View, Royal College of Surgeons of England, Lincoln's Inn Fields, London	12
	12
	11
Issue Information	11
Intramuscular Nerve Bundles Reflect TDP‐43 Pathology in the Medulla and Spinal Cord of ALS Patients	11
Axonal response of mitochondria to demyelination and complex IV activity within demyelinated axons in experimental models of multiple sclerosis	11
WNT‐activated, MYC‐amplified medulloblastoma displaying intratumoural heterogeneity	11
Interferon‐gamma contributes to disease progression in the Ndufs4(−/−) model of Leigh syndrome	11
Fibroblast growth factor 9 (FGF9)‐mediated neurodegeneration: Implications for progressive multiple sclerosis?	11
Is islet amyloid polypeptide indeed expressed in the human brain?	11
Muscle biopsy practices in the evaluation of neuromuscular disease: A systematic literature review	10
AKT1^E17K‐mutated meningioma cell lines respond to treatment with the AKT inhibitor AZD5363	10
Issue Information	10
Pathological Characterisation of Posterior Cortical Atrophy in Comparison With Amnestic Alzheimer's Disease	9
Corrigendum	9
	9
Nanopore sequencing identifies Borrelia miyamotoi as an unexpected cause of meningitis after B cell depletion	9
Issue Information	9
HnRNP K mislocalisation in neurons of the dentate nucleus is a novel neuropathological feature of neurodegenerative disease and ageing	8
Atypical teratoid/rhabdoid tumour‐TYR subtype arising in the setting of germline ring chromosome 22: An uncommon form of tumour predisposition	8
Ageing‐related tau astrogliopathy severely affecting the substantia nigra	8
	8

Low‐grade diffusely infiltrative tumour (LGDIT), SMARCB1‐mutant: A clinical and histopathological distinct entity showing epigenetic similarity with ATRT‐MYC	8
Regional redistribution of CB1 cannabinoid receptors in human foetal brains with Down's syndrome and their functional modifications in Ts65Dn^+/+ mice	8
Corrigendum	8
Quantitative cellular changes in multiple system atrophy brains	8
Amino‐terminally elongated Aβ peptides are generated by the secreted metalloprotease ADAMTS4 and deposit in a subset of Alzheimer's disease brains	8
Proteomic profiling of polyglucosan bodies associated with glycogenin‐1 deficiency in skeletal muscle	8
The SPTLC1 p.S331 mutation bridges sensory neuropathy and motor neuron disease and has implications for treatment	7
Regulation of CNS pathology by Serpina3n/SERPINA3: The knowns and the puzzles	7
Diagnostic accuracy of 1p/19q codeletion tests in oligodendroglioma: A comprehensive meta‐analysis based on a Cochrane systematic review	7
Adult brain tumour research in 2024: Status, challenges and recommendations	7
Cytoplasmic HDAC4 recovers synaptic function in the 3×Tg mouse model of Alzheimer's disease	7
Letter to the editor	7
GFAP expression in the brain during human postnatal development	7
A novel homozygous nonsense variant in COL12A1 causes myopathic Ehlers‐Danlos syndrome: A case report and literature review	7
Unfolded protein response markers Grp78 and eIF2alpha are upregulated with increasing alpha‐synuclein levels in Lewy body disease	7